Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1195 results for "dr reddy"

Indian ADRs: Wipro slips 2.3%, Dr Reddy's Lab down 2%
Money Control

Indian ADRs: Wipro slips 2.3%, Dr Reddy's Lab down 2%

Indian ADRs ended mostly lower on Thursday. Dr Reddy's Laboratories shed 2.17 percent and Tata Motors fell 1.83 percent. Money Control, 1 day ago
Dr. Reddy's Lab stock ends 2% higher India Infoline, 3 days ago

109 images for dr reddy

SleekMoney, 2 days ago, 2 days ago
Money Control, 1 day ago
Money Control, 4 days ago
Money Control, 4 days ago
Business Today India, 2 weeks ago
Money Control, 1 week ago
Fiji Times, 2 days ago
Deccan Chronicle, 4 days ago
MSN News, 2 weeks ago

Alpha Trade: Long Dr Reddy`s, short Nifty, says ICICIdirect has come out with its alpha trading strategy report. The research firm has advised to buy 1 lot of Dr Reddy's April future at Rs 3515-3525 and sell 2 lots of Nifty April future at 8660-8680, in its research report dated March 24, 2015.
 Money Control3 days ago Prefer Dr Reddy’s Labs: Mayuresh Joshi  Money Control3 days ago Prefer Dr Reddy's Labs: Mayuresh Joshi  Moneycontrol.com3 days ago Go long in Dr Reddy's Labs: Amit Gupta  Money Control1 week ago
Med India

Generic Sofosbuvir Pills for Sale in India to Treat Hepatitis C

Dr. Reddy's Laboratories Ltd (DRL), the country's second largest drug maker, has tied up with Hetero Drugs to sell the generic Sofosbuvir tablets (400mg) in India. The drug will make a significant difference in the diagnosis and treatment of Hepatitis C. "The ...
 Med India3 days ago Reddy's and Hetero to Sell Drugs for Hepatitis C  INooz3 days ago Dr. Reddy's, Hetero Drugs sign agreement to sell Hepatitis C drug  Livemint.com4 days ago Dr Reddy's partners Hetero to sell Hepatitis C drug in India  Business Standard India4 days ago
Business Standard

Dr Reddy's shares up on Hepatitis C drug launch plan

The company's market capitalisation improved by Rs 998.34 crore to Rs 59,828.22 crore Press Trust of India | Mumbai March 24, 2015 Last Updated at 17:57 IST Shares of Dr Reddy's Laboratories today settled with gains of nearly 2 per cent after the firm said it ...
 Business Standard3 days ago Dr Reddy's Labs Gains on Plans to Launch Hepatitis C Drug  NDTV Profit4 days ago Dr Reddy’s Labs plans to expand into domestic market: Report  India Infoline2 months ago
India Infoline

Dr Reddy's up 2% on pact with Hetero for Hepatitis drug

Shares of Dr Reddy's Laboratories gained 1.7 percent intraday Tuesday on agreement with Hetero to distribute and market generic version of US-firm Gilead Sciences' Hepatitis C drug under the brand 'Resof' in India.
 Money Control3 days ago Dr Reddy's, Hetero tie up for hepatitis-C drug  Financial Chronicle4 days ago Dr.Reddy's advances on Hetero tie-up  India Infoline4 days ago
Business Standard

More gains ahead for pharma stocks

Pharma stocks including the likes of Lupin, Sun Pharma, Dr Reddy's saw a bit of a sell-off last week due to profit-booking and on concerns of premium valuations for the sector. While the sector's price-to-earnings (PE) ratio has traded at a premium ...
 Business Standard India4 days ago Buy pharma stocks: Sudarshan Sukhani  Moneycontrol.com1 week ago Here's what JM Fin recommends buying in pharma space now  Money Control2 weeks ago Lupin, Sun Pharma, Dr Reddy's to get astro support: Gupta  Money Control1 month ago

Dr. Reddy's Expanding Injectable Drug Offerings, Seeking Deals

(Bloomberg) -- Dr. Reddy's Laboratories Ltd. is expanding its U.S. offerings from basic generic pills to higher-end products like generic injectable drugs and could make acquisitions of as much $1 billion as it seeks to boost growth. India's ...
 Bloomberg2 days ago

Sikki eyes Rio Olympics

Comment · print · T T T+· T- N. Sikki Reddy and Pradnya Gadre, who won the women's doubles title in the Polish International challenge.- PHOTO: By Arrangement They shuttled their way to podium finish! For, Nelakurthi Sikki Reddy ...
 The Hindu4 days ago

Stocks in news: DR Reddy's, HDIL, Aarti Drugs

5 hours ago, ET NOW Indian markets are expected to trade in a range tracking muted trend seen in other Asian markets. Take a look at the stocks making headlines in markets today. More on ET NOW: MOST POPULAR ON YAHOO TN_230315_woman_thrashed ...
 Yahoo! India3 days ago Sensex rangebound, Nifty trades around 8550 levels; ten stocks in focus  Economic Times3 days ago Sensex starts on a cautious note, Nifty trades around 8550 levels; ten stocks in focus  Economic Times4 days ago

Eye Rs 400cr increase in top line over next few yrs: Hetero

Excerpts from Closing Bell on CNBC-TV18 Watch the full show » H Speaking to CNBC-TV18, Srinivas Reddy of Hetero Drugs said the company is unlikely to make any significant impact in the first year. But in next couple of years, as number of ...
 Moneycontrol.com3 days ago See Rs 400cr increase in top line over next few yrs: Hetero  Moneycontrol.com3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less